Revenue and Profitability - The company's revenue from pesticides reached ¥9,062,370,119.54, with a gross margin of 40.99%, reflecting a year-over-year revenue increase of 63.29%[4] - Revenue from pesticides was ¥5,658,556,112.00, with a gross margin of 42.30%, showing a 68.38% increase in revenue compared to the previous year[4] - Domestic revenue amounted to ¥6,902,689,973.38, with a gross margin of 43.03%, representing a 63.49% increase year-over-year[4] - The total revenue for 2022 reached ¥1,359,845,784.87, a significant increase from ¥673,103,585.92 in 2021, representing a growth of approximately 102%[78] - The net profit for 2022 was ¥1,180,368,854.23, compared to ¥591,868,394.88 in 2021, indicating an increase of about 99%[78] - The comprehensive income for the year amounted to approximately RMB 1.48 billion[37] - The total comprehensive income for 2022 was ¥1,180,368,854.23, compared to ¥591,868,394.88 in 2021, marking a growth of approximately 99%[78] Production and Capacity - The production volume of pesticides and intermediates was 310,432.51 tons, with a sales volume of 303,657.16 tons, indicating a 72.26% increase in sales compared to the previous year[5] - A new production line with a capacity of 100,000 tons/year for ortho-nitrochlorobenzene was successfully put into operation, strengthening the company's position in the pesticide industry[52] - The company has a designed capacity of 36.3 million tons per year for its main pesticides and intermediates, with a capacity utilization rate of 85.51%[135] - The company is currently constructing an additional capacity of 40,000 tons per year for aminophenol, with an investment of approximately RMB 32,953.47 million, expected to be completed in 2023[135] Research and Development - The company has established a research and development center with a team of 359 personnel, accounting for 13.82% of the total workforce[27] - The company has developed and mastered multiple production technologies, including DAP/HAP impurity control technology and thiocyanate reaction technology, holding several patents[21] - The company aims to enhance its technological capabilities through ongoing research and development initiatives[78] - The company has implemented advanced synthesis techniques in its production processes, significantly improving product quality and reducing harmful impurities[128] Market Position and Strategy - The company plans to expand its product offerings and improve supply chain capabilities to strengthen its market position[15] - The company aims to enhance its market presence in the agricultural chemicals sector, focusing on sustainable development and high-efficiency low-toxicity products[73] - The company aims to expand its global business footprint by exploring overseas markets and increasing global registration investments[52] - The company has established long-term stable partnerships with renowned clients such as DuPont and FMC, which supports continuous business growth[22] Financial Performance and Investments - The total cash received from sales of goods and services in 2022 was approximately RMB 5.33 billion, compared to RMB 3.14 billion in 2021, indicating a significant increase[32] - Cash flow from operating activities for 2022 was ¥2,927,988,016.26, up from ¥1,410,612,292.25 in 2021, reflecting an increase of approximately 107%[83] - The company reported cash and cash equivalents at the end of 2022 amounting to ¥2,893,073,050.29, an increase from ¥2,259,071,354.55 at the end of 2021, which is a growth of about 28%[85] - The company reported a significant increase in profitability due to strong domestic and international market demand and rising raw material prices[58] Acquisitions and Partnerships - The company acquired a 70% stake in Liaoning Shixing Pharmaceutical Chemical Co., Ltd. for ¥210 million, completed on June 1, 2022[12] - The company completed the acquisition of its subsidiary, Liaoning Shixing Pharmaceutical, enhancing its integrated strategy and diversifying its product structure[52] - Future acquisitions and mergers will be considered to enrich the product line and enhance market share[192] Supply Chain and Procurement - The company has a procurement strategy that focuses on order-driven purchasing to mitigate raw material price fluctuations, with key suppliers located in several provinces[119] - The company has a rigorous supplier qualification process, ensuring that new suppliers meet quality and capability standards before being approved[120] Regulatory and Compliance - The company’s financial statements comply with accounting standards, reflecting its financial position and operating results accurately[149] - The company’s consolidated financial statements reflect the overall financial status and cash flows of the entire corporate group[164] Talent and Human Resources - The company emphasizes the importance of attracting and retaining talent to drive its development[190] - The company has a strong focus on technological innovation, with a dedicated committee led by the chairman to oversee development and innovation efforts[125]

证券代码：603599 证券简称：广信股份 公告编号：2023-015 安徽广信农化股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责 任。 重要内容提示： 会议召开时间：2023 年 04 月 28 日(星期五) 上午 11:00- 12:00 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 04 月 25 日(星期二) 至 04 月 27 日(星期 四)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 guangxinzq@chinaguangxin.com 进行提问。公司将在 说明会上对投资者普遍关注的问题进行回答。 安徽广信农化股份有限公司（以下简称"公司"）已于 2023 年 4 月 25 日发布公司 2022 年度报告，为便于广大投资者更全面深入 地了解公司 2022 年度经营成果、财务状况，公司计划于 2023 ...

2022 年第三季度报告 单位：元 币种：人民币 1 / 13 证券代码：603599 证券简称：广信股份 安徽广信农化股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 | --- | --- | --- | --- | --- | |------------------------------------------------|------------------------|-----------------------------------------|------------------------|---------- ...

Financial Performance - The company reported a total revenue of 1.2 billion RMB for the first half of 2022, representing a year-on-year increase of 15%[21]. - The net profit attributable to shareholders reached 200 million RMB, up 10% compared to the same period last year[21]. - Revenue for the reporting period (January to June) reached ¥4,502,529,254.63, an increase of 79.44% compared to the same period last year[23]. - Net profit attributable to shareholders was ¥1,243,285,943.89, reflecting a growth of 97.23% year-over-year[23]. - Net profit excluding non-recurring gains and losses increased by 102.89% to ¥1,173,722,902.87 compared to the previous year[23]. - Net cash flow from operating activities rose by 101.07% to ¥1,463,658,939.21, driven by increased sales and profit[23]. - Basic earnings per share increased by 96.91% to ¥1.91, attributed to significant growth in revenue and profit[23]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY for the first half of 2022, representing a 15% year-over-year growth[100]. - The net profit for the first half of 2022 was CNY 1,264,581,029.93, representing a 100.8% increase from CNY 630,360,928.70 in the same period of 2021[179]. - The total comprehensive income for the first half of 2022 was CNY 1,264,581,029.93, compared to CNY 630,360,928.70 in the same period of 2021, indicating a growth of 100.8%[179]. User Growth and Market Expansion - The company expanded its user base by 25%, reaching a total of 500,000 active users in the reporting period[21]. - User data indicates a growth in active users, reaching 5 million, which is a 20% increase compared to the previous year[100]. - The company plans to launch two new products in Q3 2022, aiming to capture an additional 5% market share[21]. - The company plans to expand its market presence by entering three new provinces in China by the end of 2022, aiming for a 25% increase in market share[100]. - A strategic acquisition of a local competitor is in progress, which is anticipated to increase the company's customer base by 15%[100]. Research and Development - Research and development expenses increased by 20%, totaling 50 million RMB, focusing on new pesticide formulations[21]. - Research and development expenses increased by 58.83% to CNY 219,458,089.11, indicating a strong commitment to innovation[45]. - The company has committed to investing 100 million CNY in research and development for innovative product lines over the next two years[100]. Financial Guidance and Projections - The management provided a revenue guidance of 2.5 billion RMB for the full year 2022, indicating a growth target of 12%[21]. - The company has set a future outlook with a revenue target of 2.5 billion CNY for the full year 2022, indicating a projected growth of 10%[100]. Risk Management - The company has identified key risks including raw material price fluctuations and regulatory changes in the agricultural sector[21]. - The company faces risks related to safety and environmental regulations, particularly in the chemical industry[59]. - Raw material costs account for 82% of production costs, making the company vulnerable to price fluctuations in key raw materials[60]. Environmental Compliance and Initiatives - The company has implemented pollution control facilities, ensuring stable and compliant emissions from its operations[77]. - The company achieved wastewater discharge compliance with standards, including CODcr levels of 9.9957 mg/L and ammonia nitrogen levels of 1.0344 mg/L[72]. - The company has committed to energy management and carbon emission reduction, establishing an energy management office to improve energy efficiency[87]. - The company has reported no administrative penalties related to environmental issues during the reporting period, indicating compliance with environmental regulations[84]. - The company has actively promoted environmental protection measures, focusing on reducing emissions of waste and pollutants, and has successfully implemented multiple modification projects[86]. Corporate Governance and Shareholder Information - The company reported no significant non-operational fund occupation by controlling shareholders during the reporting period[21]. - The company reported no significant legal disputes or regulatory penalties during the reporting period, reflecting a stable operational environment[100]. - The board of directors is actively monitoring the implementation of corporate governance practices to ensure transparency and accountability[100]. - The number of ordinary shareholders at the end of the reporting period is 16,137[147]. - The largest shareholder, Anhui Guangxin Group Co., Ltd., holds 263,843,504 shares, accounting for 40.57% of the total shares[147]. Asset and Liability Management - Total assets grew by 41.17% to ¥11,497,461,797.69 compared to the end of the previous year[23]. - The total liabilities amounted to CNY 5,194,660,908.78, an increase of 11.8% from CNY 4,647,563,392.83 in the previous year[178]. - Owner's equity increased to ¥7,855,335,078.09 from ¥6,959,116,281.47, showing an increase of about 12.8%[166].

Financial Performance - The company's operating revenue for 2021 reached ¥5,549,906,816.60, representing a year-on-year increase of 63.12%[22]. - The net profit attributable to shareholders for 2021 was ¥1,479,380,288.82, reflecting a significant growth of 151.28% compared to the previous year[22]. - The net cash flow from operating activities increased by 103.94% year-on-year, amounting to ¥1,410,612,292.25, primarily due to rising product prices and increased net profit[25]. - Total assets grew by 37.83% year-on-year, reaching ¥10,153,035,662.82, driven by enhanced profitability and increases in cash, investments, and inventory[25]. - Basic earnings per share for 2021 were ¥3.18, up 150.39% from the previous year, attributed to substantial growth in operating revenue and profit[25]. - The weighted average return on equity increased by 12.66 percentage points to 23.59% in 2021, indicating improved profitability[22]. - The net profit after deducting non-recurring gains and losses rose by 184.62% year-on-year to ¥1,376,145,702.21, driven by significant revenue growth[25]. - The company reported a net profit of ¥446,499,750.48 in Q4 2021, showing a steady increase throughout the year[26]. - The company experienced a net cash flow from operating activities of -¥218,166,559.40 in Q4 2021, indicating fluctuations in cash flow management[26]. Dividend and Share Capital - The company plans to distribute a cash dividend of 10 CNY per 10 shares, totaling 464,564,135 CNY, and will increase its share capital by 185,825,654 shares through a capital reserve conversion, raising total shares to 650,389,789[7]. - The company has a cash dividend policy that prioritizes cash dividends, aiming for a minimum of 30% of the average distributable profit over three consecutive years to be distributed in cash when conditions are met[166]. - The company approved a profit distribution plan for 2021, proposing a cash dividend of 10 RMB per 10 shares (including tax) and a capital reserve conversion of 4 shares for every 10 shares, totaling a cash distribution of 464,564,135 RMB and an increase in total shares to 650,389,789[171]. Risk Management - The company reported no significant risks that could materially affect its operations during the reporting period[8]. - The company has outlined various risks and countermeasures in its management discussion and analysis section[8]. - The company has a comprehensive risk management strategy in place to address potential operational challenges[8]. - The company has no non-operating fund occupation by controlling shareholders or related parties[8]. - The company has no violations of decision-making procedures regarding external guarantees[8]. Audit and Compliance - The audit report issued by Rongcheng Accounting Firm confirmed the financial statements' authenticity and completeness, with a standard unqualified opinion[6]. - The company has established a strict internal control management system in compliance with regulations, ensuring legal and compliant operations and asset security[176]. - The company has disclosed its internal control audit report, which received a standard unqualified opinion[178]. - The company has not faced any penalties from securities regulatory agencies in the past three years[145]. Market and Industry Position - The global pesticide market demand remained strong in 2021 due to post-pandemic monetary easing and increased focus on food security, leading to a rise in pesticide demand[35]. - The company's sales growth was driven by the release of new production capacity, strong domestic and international market demand, and increased product prices due to rising raw material costs[41]. - The company is one of the few listed firms capable of large-scale production of ortho-nitrochlorobenzene and is a major production base for the fungicide carbendazim[40]. - The domestic pesticide industry has seen steady growth in sales and profits, with the company benefiting from the resilience of the pesticide supply chain amid global economic challenges[39]. - The company has a competitive edge in the market due to its comprehensive production system and a wide range of pesticide products[42]. Research and Development - Research and development expenses increased by 54.18% to CNY 278,518,554.68, indicating a commitment to innovation[53]. - The company has developed and mastered several production technologies, including DAP/HAP impurity control technology and thiocyanate reaction technology[48]. - The company is committed to sustainable development and improving the quality and efficiency of its operations[112]. - The company aims to enhance its research and development capabilities in response to industry trends and regulatory changes, particularly in the chemical sector[82]. - The company has invested in R&D since its establishment, with a technology center that has undertaken multiple national science and technology projects, resulting in numerous patents and recognition as a high-tech enterprise[96]. Environmental Responsibility - The company has established a wastewater treatment plant with a daily processing capacity of 5,000 tons, effectively treating high-salinity and low-salinity wastewater[188]. - The wastewater treatment process includes advanced methods such as iron-carbon micro-electrolysis and multi-effect evaporation, ensuring compliance with discharge standards[190]. - Emissions from the thermal power boiler are within regulatory limits, with sulfur dioxide at 5.803 mg/m³, nitrogen oxides at 23.772 mg/m³, and particulate matter at 0.133 mg/m³[186]. - The company has implemented comprehensive noise control measures, including the use of low-noise equipment and sound insulation techniques[189]. - The company has a robust hazardous waste management system, ensuring compliance with regulations and proper disposal of hazardous materials[193]. - The company has actively pursued green development initiatives, focusing on waste reduction and energy efficiency improvements[200]. - The company has established a carbon emission management system to promote energy efficiency and reduce greenhouse gas emissions[200]. Governance and Management - The board of directors has ensured that all members attended the board meeting, affirming the report's accuracy and completeness[5]. - The management team includes experienced professionals with backgrounds in finance, technology, and management, contributing to strategic decision-making[134]. - The board of directors is composed of individuals with diverse professional experiences, enhancing governance and oversight capabilities[136]. - The company emphasizes a people-oriented approach to human resource development, aiming to create a supportive work environment and attract talent[116]. - The company has a structured employee compensation system based on positions, with annual performance bonuses as a supplement, and provides benefits such as social insurance and paid leave[161]. Production and Operations - The company achieved a production capacity of 26.1 million tons per year with a utilization rate of 74.54%[100]. - The company has a land reserve of 4,200 acres across its two production bases, providing a strong foundation for future expansion[85]. - The company has established a complete R&D, procurement, production, testing, and sales system, adopting an "order-driven + safety stock" business model[86]. - The company’s main products, including multi-bacterial agents and methyl thiophanate, rank among the top in domestic production and sales, with high profit margins in the industry[92]. Shareholder Engagement - The company actively communicates with shareholders, especially small shareholders, to gather their opinions and address their concerns regarding cash dividends[170]. - The company is committed to encouraging participation from small and institutional investors in profit distribution decisions, leveraging professional guidance from intermediaries[170]. - The company has a mechanism in place to deduct cash dividends from shareholders who have illegally occupied company funds[170].

Financial Performance - The company's operating revenue for Q1 2022 was ¥2,056,692,232.95, representing a 64.39% increase compared to the same period last year [6] - Net profit attributable to shareholders was ¥569,169,538.35, reflecting a 101.90% year-over-year growth [6] - Basic earnings per share (EPS) was ¥1.23, up by 101.64% year-over-year [6] - Operating profit for Q1 2022 was ¥672,936,873.02, up 108.5% from ¥322,885,938.38 in Q1 2021 [30] - Net profit attributable to shareholders for Q1 2022 was ¥569,169,538.35, representing a 102.1% increase from ¥281,903,176.13 in Q1 2021 [32] - Total equity attributable to shareholders rose to ¥7,544,804,007.72 in Q1 2022, up from ¥6,959,116,281.47 in Q1 2021, an increase of 8.4% [30] Cash Flow - The net cash flow from operating activities reached ¥746,432,072.51, a significant increase of 280.34% compared to the previous year [6] - Cash inflow from operating activities for Q1 2022 was approximately $1.48 billion, a significant increase from $910.67 million in Q1 2021, representing a growth of about 62.5% [35] - Net cash flow from operating activities reached $746.43 million in Q1 2022, compared to $196.25 million in Q1 2021, indicating a substantial increase of approximately 280.5% [35] - Cash inflow from investment activities totaled approximately $1.97 billion in Q1 2022, up from $1.66 billion in Q1 2021, reflecting an increase of about 18.7% [36] - The net increase in cash and cash equivalents for Q1 2022 was $282.17 million, contrasting with a decrease of $79.57 million in Q1 2021 [36] - The ending balance of cash and cash equivalents as of Q1 2022 was approximately $2.54 billion, compared to $1.50 billion at the end of Q1 2021, marking an increase of about 70% [36] Assets and Liabilities - Total assets at the end of the reporting period were ¥11,400,037,517.42, an increase of 12.28% from the end of the previous year [9] - Current assets totaled RMB 8,827,531,855.26, up from RMB 7,711,881,318.96 year-over-year [21] - Total liabilities increased to ¥3,855,233,509.70 in Q1 2022 from ¥3,193,919,381.35 in Q1 2021, marking a growth of 21.0% [30] - Total current liabilities reached RMB 3,749,717,680.01, compared to RMB 3,086,094,674.41, marking an increase of approximately 21.5% [24] - Non-current assets totaled RMB 2,572,505,662.16, up from RMB 2,441,154,343.86, reflecting an increase of about 5.4% [24] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 14,087 [16] - The largest shareholder, Anhui Guangxin Group Co., Ltd., held 40.57% of the shares [16] - The company reported a total of 188,459,646 shares held by Anhui Guangxin Group Co., Ltd., the largest shareholder [18] Research and Development - Research and development expenses rose by 73.77%, indicating increased investment in innovation [15] - Research and development expenses for Q1 2022 were ¥89,267,582.42, a 73.5% increase from ¥51,370,584.14 in Q1 2021 [30] Other Information - The company reported non-recurring gains of ¥30,792,509.18 during the quarter [12] - The company has not disclosed any significant new strategies or product developments during the reporting period [19]

Financial Performance - The company's operating revenue for Q3 2021 reached ¥1,618,552,930.91, representing a year-on-year increase of 72.51%[7] - Net profit attributable to shareholders for the same period was ¥402,519,609.64, a significant increase of 165.72% compared to the previous year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥379,495,011.35, up 224.63% year-on-year[7] - Basic earnings per share for Q3 2021 were ¥0.86, reflecting a 160.61% increase from the same period last year[10] - Net profit for the third quarter of 2021 was ¥1,032,880,538.34, compared to ¥435,452,932.40 in the third quarter of 2020, indicating a year-over-year increase of about 137.5%[39] - Operating profit for the third quarter was ¥1,174,198,591.92, up from ¥509,887,689.86 in the same quarter of the previous year, representing a growth of approximately 130.0%[39] - The total comprehensive income for the period reached CNY 1,032,880,538.34, compared to CNY 435,452,932.40 in the same period last year, indicating a significant increase[41] - Basic and diluted earnings per share were both CNY 2.22, up from CNY 0.94 year-over-year[41] Assets and Liabilities - Total assets at the end of Q3 2021 amounted to ¥9,304,726,259.81, a 26.32% increase compared to the end of the previous year[10] - The company's total current assets as of September 30, 2021, amount to 6,849,800,966.08 RMB, an increase from 5,194,663,259.58 RMB at the end of 2020[26] - The total assets of the company as of September 30, 2021, are 9,304,726,259.81 RMB, compared to 7,366,221,966.30 RMB at the end of 2020[29] - The total non-current assets are 2,454,925,293.73 RMB, an increase from 2,171,558,706.72 RMB at the end of 2020[29] - Total liabilities amounted to ¥2,815,636,968.15, up from ¥1,724,039,184.28, reflecting an increase of approximately 63.4%[30] - The total liabilities include accounts payable of 1,386,684,795.30 RMB, up from 1,041,766,697.61 RMB year-over-year[29] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥1,628,778,851.65, showing a 100.26% increase[10] - Cash inflow from operating activities totaled CNY 4,204,531,465.21, a substantial increase from CNY 1,907,610,530.36 in the previous year[44] - The net cash flow from operating activities was CNY 1,628,778,851.65, compared to CNY 813,349,010.13 in the same period last year[44] - Cash outflow from investment activities amounted to CNY 6,988,146,076.19, compared to CNY 9,687,960,111.54 in the previous year, resulting in a net cash flow from investment activities of -CNY 1,212,855,217.46[44] - The net cash flow from financing activities was -CNY 200,099,128.05, compared to -CNY 150,901,348.78 in the same period last year[44] - The cash and cash equivalents at the end of the period were CNY 1,795,901,679.50, up from CNY 1,369,454,226.18 at the end of the same period last year[46] Shareholder Information - Total number of common shareholders at the end of the reporting period is 16,148[20] - The largest shareholder, Anhui Guangxin Group Co., Ltd., holds 175,450,000 shares, accounting for 37.76% of total shares[20] - The company has a total of 8,000,000 shares held by China Industrial Bank Co., Ltd. - Fortune Tianhui Selected Growth Mixed Securities Investment Fund[20] Market and Growth Strategy - The company attributed the increase in revenue and profit to favorable market conditions and rising product prices[16] - The company has plans for market expansion and new product development to sustain growth in the upcoming quarters[16] Research and Development - Research and development expenses for the first three quarters of 2021 were ¥224,187,680.62, compared to ¥138,070,808.34 in the same period of 2020, indicating an increase of about 62.3%[35] Operating Costs - The company reported a total operating cost of ¥3,033,970,025.09 for the first three quarters of 2021, up from ¥2,270,816,711.89 in the same period of 2020, which is an increase of about 33.6%[35]

Financial Performance - The company's operating revenue for Q3 2021 reached ¥1,618,552,930.91, representing a year-on-year increase of 72.51%[7] - Net profit attributable to shareholders was ¥402,519,609.64, a significant increase of 165.72% compared to the same period last year[7] - The basic earnings per share (EPS) for the quarter was ¥0.86, reflecting a 160.61% increase year-on-year[10] - Total operating revenue for the first three quarters of 2021 reached ¥4,127,750,276.93, a significant increase from ¥2,706,270,886.51 in the same period of 2020, representing a growth of approximately 52.5%[38] - Net profit for the third quarter of 2021 was ¥1,032,880,538.34, compared to ¥435,452,932.40 in the third quarter of 2020, indicating a year-over-year increase of about 137.5%[40] - The company's total operating profit for the third quarter of 2021 was ¥1,174,198,591.92, compared to ¥509,887,689.86 in the same quarter of 2020, showing an increase of approximately 130.0%[40] - The total comprehensive income for the period reached ¥1,032,880,538.34, compared to ¥435,452,932.40 in the same period last year, indicating a significant increase[42] - Basic and diluted earnings per share were both ¥2.22, up from ¥0.94 in the previous year[42] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥9,304,726,259.81, marking a 26.32% increase from the end of the previous year[10] - The company's total current assets as of September 30, 2021, amount to approximately ¥6.85 billion, an increase from ¥5.19 billion at the end of 2020[29] - The total assets of the company are approximately ¥9.30 billion, up from ¥7.37 billion at the end of 2020[32] - The company's inventory as of September 30, 2021, is approximately ¥953.76 million, compared to ¥763.73 million at the end of 2020, reflecting a growth of about 25%[30] - Total liabilities increased to ¥2,815,636,968.15 from ¥1,724,039,184.28, reflecting a growth of approximately 63.4%[37] - The total equity attributable to shareholders rose to ¥6,489,089,291.66, a 15.01% increase from the previous year[10] - The total equity attributable to shareholders rose to ¥6,489,089,291.66, up from ¥5,642,182,782.02, marking an increase of about 15.0%[39] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥1,628,778,851.65, showing a 100.26% increase compared to the same period last year[10] - Cash inflows from operating activities totaled ¥4,204,531,465.21, compared to ¥1,907,610,530.36 in the same period last year, reflecting a strong growth in operational cash flow[46] - Net cash flow from operating activities was ¥1,628,778,851.65, an increase from ¥813,349,010.13 year-over-year[46] - Cash and cash equivalents at the end of the period were ¥1,795,901,679.50, up from ¥1,369,454,226.18 at the end of the same period last year[48] - The company experienced a net increase in cash and cash equivalents of ¥220,829,331.67, compared to an increase of ¥764,600,867.51 in the same period last year[48] Research and Development - Research and development expenses increased by 62.37% year-on-year, indicating a commitment to innovation[21] - Research and development expenses for the first three quarters of 2021 amounted to ¥224,187,680.62, up from ¥138,070,808.34 in the same period of 2020, representing a growth of about 62.3%[38] Shareholder Information - The total number of common shareholders at the end of the reporting period is 16,148[22] - The largest shareholder, Anhui Guangxin Group Co., Ltd., holds 175,450,000 shares, accounting for 37.76% of total shares[25] - The total number of shares held by the top ten shareholders includes significant stakes from state-owned and private entities, indicating a diverse ownership structure[25] - The company has no preferred shareholders with restored voting rights as of the reporting period[22] - The company has not disclosed any significant financing or margin trading activities involving its top shareholders[28] Other Financial Metrics - The accounts receivable increased by 37.97% due to a significant rise in sales revenue[18] - The company reported a 143.89% increase in contract liabilities, driven by a surge in orders[18] - The financial expenses saw a dramatic increase of 2,096.43%, primarily due to increased exchange gains during the reporting period[21] - Deferred income decreased to ¥49,793,365.18 from ¥59,868,226.35, reflecting a decline of about 16.7%[37] - The company reported a significant increase in cash received from other operating activities, totaling ¥139,561,702.33, compared to ¥85,896,680.07 last year[46] - Cash outflows from investing activities amounted to ¥6,988,146,076.19, compared to ¥9,687,960,111.54 in the previous year, indicating a reduction in investment spending[46] - The net cash flow from investing activities was -¥1,212,855,217.46, a decline from a positive cash flow of ¥112,774,277.57 in the same period last year[46] - The company reported a significant increase in fixed assets, totaling approximately ¥1.31 billion, compared to ¥1.27 billion at the end of 2020[30]

Financial Performance - The company's operating revenue for the first half of 2021 reached ¥2,509,197,346.02, representing a 41.92% increase compared to ¥1,768,046,353.23 in the same period last year[19]. - Net profit attributable to shareholders was ¥630,360,928.70, a significant increase of 121.98% from ¥283,969,553.76 in the previous year[19]. - The net profit after deducting non-recurring gains and losses was ¥578,511,380.09, up 147.51% from ¥233,730,453.98 year-on-year[19]. - The net cash flow from operating activities was ¥727,944,931.09, an increase of 23.23% compared to ¥590,715,339.95 in the same period last year[19]. - Basic earnings per share for the first half of 2021 were ¥1.36, a 122.95% increase from ¥0.61 in the same period last year[22]. - The weighted average return on net assets rose to 10.58%, an increase of 5.15 percentage points compared to 5.43% in the previous year[22]. - The significant growth in revenue and net profit was attributed to the recovery of the domestic economy and improved market conditions in the chemical industry following the easing of the global COVID-19 pandemic[22]. Assets and Liabilities - The company's total assets at the end of the reporting period were ¥8,144,123,698.18, reflecting a 10.56% increase from ¥7,366,221,966.30 at the end of the previous year[19]. - The net assets attributable to shareholders increased to ¥6,098,719,990.11, an 8.09% rise from ¥5,642,182,782.02 at the end of the previous year[19]. - Total liabilities increased to ¥2,045,403,708.07 from ¥1,724,039,184.28, reflecting a rise of about 18.6%[163]. - Current liabilities rose to ¥2,779,188,863.56, up from ¥2,078,024,694.97, indicating a 33.7% increase[171]. Research and Development - Research and development expenses increased by 42.67% to CNY 138.17 million, reflecting the company's commitment to innovation[41]. - The company has invested in technology development to improve product quality and develop new products[27]. - The company has a strong focus on R&D, continuously investing in technology upgrades and product quality improvements, which has led to a virtuous cycle of production and innovation[34]. Market and Sales Strategy - The company focuses on the research, production, and sales of pesticide raw materials and fine chemical intermediates, with key products including multi-bacterial spirit and glyphosate[27]. - The sales strategy includes a dual focus on domestic and international markets, with significant customer bases in North America, Europe, and Southeast Asia[30]. - The company emphasizes direct sales to enhance brand value and maintain stable customer relationships[30]. Environmental and Safety Compliance - The company has implemented comprehensive environmental protection measures, ensuring that pollutant emissions meet national and local standards, while also developing clean production and circular economy initiatives[50]. - The company has made significant investments in environmental facilities and management measures to mitigate pollution risks[50]. - The company is committed to continuous improvement in safety and environmental performance, aligning with national sustainable development strategies[50]. - The company has established a wastewater treatment station with a daily processing capacity of 5,000 tons, ensuring that treated wastewater meets the standards for discharge into the park's sewage treatment plant[71]. Corporate Social Responsibility - The company donated 100,000 tons of disinfectant and over 10,000 masks for COVID-19 prevention since 2020[89]. - The company actively contributed to education, elderly care, medical assistance, disability support, poverty alleviation, and orphan care in 2021, showcasing its corporate social responsibility[89]. Shareholder Information - The total number of shares after the recent change is 464,649,135, reflecting a decrease of 30,000 shares[139]. - The top shareholder, Anhui Guangxin Group Co., Ltd., held 195,460,000 shares, accounting for 42.06% of the total shares[145]. - The company has not provided any guarantees to shareholders, actual controllers, or their related parties during the reporting period[133]. - There were no significant lawsuits or arbitration matters during the reporting period[127].

Financial Performance - The company's operating revenue for 2020 was CNY 3,402,428,649.14, representing a 9.39% increase compared to CNY 3,110,364,091.99 in 2019[26] - The revenue after deducting non-core business income was CNY 3,387,116,492.52, which is a 9.57% increase from CNY 3,091,280,750.86 in the previous year[26] - The net profit attributable to shareholders was CNY 588,733,508.52, an increase of 16.43% compared to CNY 505,652,658.28 in the previous year[29] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 484,008,196.77, up 26.68% from CNY 382,070,303.52 in 2019[29] - The basic earnings per share increased to CNY 1.27, reflecting a growth of 16.51% from CNY 1.09 in 2019[30] - The total assets at the end of 2020 were CNY 7,366,221,966.30, representing an increase of 11.63% from CNY 6,598,688,562.55 at the end of 2019[29] - The company achieved a consolidated revenue of 3.402 billion RMB, representing a year-on-year growth of 9.39%[53] - The net profit attributable to the parent company was 589 million RMB, reflecting a year-on-year increase of 16.43%[53] Cash Flow and Investments - The net cash flow from operating activities was CNY 691,671,491.33, a slight decrease of 0.49% compared to CNY 695,053,444.24 in the previous year[29] - The company’s investment activities generated a net cash inflow of 426.53 million RMB, a significant improvement from the previous year[59] - The cash flow from operating activities was 691.67 million RMB, a slight decrease of 0.49% year-on-year[59] - The company reported a significant increase in cash flow from investing activities, totaling ¥426,529,341.34 in 2020, compared to a negative cash flow of ¥1,141,436,959.74 in 2019[72] - The company's cash and cash equivalents at the end of 2020 reached ¥1,731,350,301.25, a 153.79% increase from ¥682,190,548.04 in the previous year[76] Research and Development - The company is committed to enhancing its research and development capabilities to innovate new products and technologies in the agricultural chemicals market[26] - The company applied for 71 new patents and received 29 patent authorizations during the reporting period[54] - Research and development expenses increased by 11.19% to 180.65 million RMB compared to the previous year[69] - The company's total R&D investment for 2020 amounted to ¥180,648,073.09, representing 5.31% of total revenue[71] - The company has a technology center established in 2003, focusing on research and development, and has undertaken multiple national technology projects[96][97] Product and Market Strategy - The company has developed a leading technological innovation system in the pesticide industry, with multiple core technologies including phosgene synthesis and impurity control[43] - The company aims to balance pesticide market demand through a diverse range of products to mitigate the impact of climate variability[39] - Future product development will focus on high-efficiency, low-toxicity pesticide varieties and fine chemical intermediates, including new pesticides and important intermediates for pharmaceuticals and new materials[126] - The company plans to adjust its product structure to improve its core competitiveness in both domestic and international markets[124] - The company’s main products include multi-fungicides, methyl thiophanate, and dicamba, with production processes that meet international quality standards[100][101][102] Corporate Governance and Compliance - The board of directors confirmed that all members attended the board meeting, ensuring governance and oversight[5] - The audit report issued by Rongcheng Accounting Firm was a standard unqualified opinion, ensuring the accuracy of the financial report[6] - The company reported no significant risks that could materially affect its operations during the reporting period[8] - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties[8] - The company has committed to ensuring that its actual controllers comply with relevant laws and regulations regarding related party transactions[162] Shareholder Relations and Dividends - The profit distribution plan for 2020 proposes a cash dividend of CNY 4.30 per 10 shares, totaling CNY 199,812,028.05 based on a total share capital of 464,679,135 shares as of December 31, 2020[7] - The company has committed to maintaining communication with minority shareholders regarding cash dividend proposals and ensuring their opinions are considered[149] - The cash dividend for 2020 was RMB 4.3 per 10 shares, while no dividends were declared in 2019[151] - The company has a cash dividend policy that prioritizes cash distributions, aiming for a minimum of 30% of the average distributable profit over three consecutive years to be distributed in cash[145] Risk Management and Challenges - The overall economic environment is expected to present significant challenges in 2021, with increased pressure on the company[120] - Approximately one-third of the company's revenue comes from exports, making it sensitive to fluctuations in the RMB/USD exchange rate, which could impact overall profitability[134] - The company has not proposed a cash profit distribution plan for the previous fiscal year despite having positive distributable profits, and it must disclose the reasons and intended use of retained earnings[155] Sustainability and Social Responsibility - The company is focused on sustainable development and social responsibility, emphasizing employee well-being and environmental stewardship[200] - The company has a clear mission to innovate in agricultural technology and serve the green industry, aligning with its operational guidelines[200] - The company has a strong focus on safety and environmental protection, achieving compliance with high standards and receiving no major penalties during the reporting period[53]